IPSC - Century Therapeutics GAAP EPS of -$2.27 beats by $0.05 revenue of $5.2M misses by $1.76M March, 16 2023 07:33 AM Century Therapeutics Inc. 2023-03-16 07:33:38 ET Century Therapeutics press release ( NASDAQ: IPSC ): FY GAAP EPS of -$2.27 beats by $0.05 . Revenue of $5.2M misses by $1.76M . For further details see: Century Therapeutics GAAP EPS of -$2.27 beats by $0.05, revenue of $5.2M misses by $1.76M